Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: Sadif Analytics (Premium)
Provider: Wright Reports
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Venaxis Inc Files For CE Mark Approval

Friday, 21 Dec 2012 07:30am EST 

Venaxis Inc announced that it has filed for CE Mark approval in Europe for APPY1, the Company's blood-based appendicitis test. Based upon the standard protocol for submission of technical file for APPY1 through the Company's authorized representative, Venaxis expects to obtain CE Mark under the European Economic Area by the end of the year. 

Company Quote

0.02 +1.17%
22 Aug 2014